Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Liposomal daunorubicin

EU orphan designation number: EU/3/12/1056   
Active ingredient: Liposomal daunorubicin
Indication: Treatment of acute myeloid leukaemia
Sponsor: Galen limited
Seagoe Industrial Estate, Craigavon, BT63 5UA, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/10/2012 Orphan Designation EMA/OD/105/12 (2012)7233 of 10/10/2012